Insider Selling: athenahealth, Inc (NASDAQ:ATHN) CEO Sells 25,000 Shares of Stock

athenahealth, Inc (NASDAQ:ATHN) CEO Jonathan Bush sold 25,000 shares of the stock in a transaction on Monday, February 5th. The shares were sold at an average price of $145.00, for a total transaction of $3,625,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Jonathan Bush also recently made the following trade(s):

  • On Thursday, February 1st, Jonathan Bush sold 5,000 shares of athenahealth stock. The shares were sold at an average price of $122.69, for a total transaction of $613,450.00.
  • On Tuesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The shares were sold at an average price of $134.80, for a total transaction of $4,044,000.00.
  • On Tuesday, December 26th, Jonathan Bush sold 30,000 shares of athenahealth stock. The shares were sold at an average price of $134.80, for a total transaction of $4,044,000.00.

athenahealth, Inc (NASDAQ ATHN) traded down $2.42 during trading hours on Friday, reaching $138.82. 372,244 shares of the company were exchanged, compared to its average volume of 603,367. athenahealth, Inc has a 1-year low of $95.01 and a 1-year high of $158.66. The company has a market capitalization of $5,460.00, a price-to-earnings ratio of 111.95, a price-to-earnings-growth ratio of 2.98 and a beta of 1.35. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.48. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. During the same period last year, the firm earned $0.62 earnings per share. athenahealth’s revenue for the quarter was up 14.2% compared to the same quarter last year. analysts anticipate that athenahealth, Inc will post 2.29 EPS for the current fiscal year.

A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in athenahealth by 1.4% in the 4th quarter. BlackRock Inc. now owns 1,661,698 shares of the health services provider’s stock valued at $221,073,000 after buying an additional 22,767 shares during the period. Allianz Asset Management GmbH increased its holdings in athenahealth by 67.0% in the 4th quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock valued at $73,939,000 after buying an additional 223,006 shares during the period. Jackson Square Partners LLC increased its holdings in athenahealth by 1.1% in the 4th quarter. Jackson Square Partners LLC now owns 531,549 shares of the health services provider’s stock valued at $70,717,000 after buying an additional 5,811 shares during the period. State Street Corp increased its holdings in athenahealth by 2.0% in the 2nd quarter. State Street Corp now owns 512,675 shares of the health services provider’s stock valued at $72,052,000 after buying an additional 9,852 shares during the period. Finally, ArrowMark Colorado Holdings LLC increased its holdings in athenahealth by 30.1% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock valued at $68,098,000 after buying an additional 118,411 shares during the period.

A number of brokerages have commented on ATHN. BidaskClub upgraded shares of athenahealth from a “strong sell” rating to a “sell” rating in a research note on Saturday. Piper Jaffray Companies reissued a “buy” rating and issued a $160.00 price objective on shares of athenahealth in a research report on Friday. Royal Bank of Canada set a $141.00 price objective on shares of athenahealth and gave the company a “hold” rating in a research report on Thursday. SunTrust Banks increased their price objective on shares of athenahealth to $180.00 and gave the company a “buy” rating in a research report on Monday, February 5th. Finally, ValuEngine lowered shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. Three investment analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and seven have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $144.23.

ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/17/insider-selling-athenahealth-inc-athn-ceo-sells-3625000-00-in-stock.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply